Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”

Stephen Senn

doi:10.1080/19466315.2024.2375232

Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”

Stephen Senn^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

5 Citations (Scopus)

Original language	English
Pages (from-to)	414-416
Number of pages	3
Journal	Statistics in Biopharmaceutical Research
Volume	16
Issue number	4
DOIs	https://doi.org/10.1080/19466315.2024.2375232
Publication status	Published - 2024
Externally published	Yes

Access to Document

10.1080/19466315.2024.2375232

Cite this

@article{a00c3d1ec7a1424692cbbb3633e7c05d,

title = "Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”",

author = "Stephen Senn",

year = "2024",

doi = "10.1080/19466315.2024.2375232",

language = "English",

volume = "16",

pages = "414--416",

journal = "Statistics in Biopharmaceutical Research",

issn = "1946-6315",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials

T2 - A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”

AU - Senn, Stephen

PY - 2024

Y1 - 2024

UR - https://www.scopus.com/pages/publications/85207180687

U2 - 10.1080/19466315.2024.2375232

DO - 10.1080/19466315.2024.2375232

M3 - Comment/debate

AN - SCOPUS:85207180687

SN - 1946-6315

VL - 16

SP - 414

EP - 416

JO - Statistics in Biopharmaceutical Research

JF - Statistics in Biopharmaceutical Research

IS - 4

ER -

Comment on “Using Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions”

Access to Document

Other files and links

Cite this